Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAY.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
GM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BQ.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AY.129 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAY.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CM.8.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.7.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CH.1.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FK.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.26.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DS.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.5.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DV.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.11.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.4.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.60SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used